Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes

被引:131
作者
Carlotti, F
Bazuine, M
Kekarainen, T
Seppen, J
Pognonec, P
Maassen, JA
Hoeben, RC
机构
[1] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Virus Biol Lab, NL-2333 AL Leiden, Netherlands
[2] Univ Nice, UMR 6548, Fac Sci, F-06108 Nice, France
[3] Acad Med Ctr, Dept Expt Hepatol, NL-1105 BK Amsterdam, Netherlands
关键词
gene transfer; 3T3-L1; adipocyte; lentivirus; obesity; ectopic expression; adenovirus; insulin;
D O I
10.1016/j.ymthe.2003.11.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Obesity is associated with many serious afflictions such as cardiovascular disease, cancer, and diabetes. One of the main cellular systems used to study the underlying physiological and biological processes is the 3T3-L1 preadipocyte differentiation model. However, studies on 3T3-L1 adipocytes are hampered by the fact that genetic modification of mature adipocytes is notoriously difficult. In this report, we evaluated the use of lentivirus-mediated gene transfer into 3T3-L1 mature adipocytes. We demonstrate that quiescent, fully differentiated 3T3-L1 adipocytes as well as 3T3-L1 preadipocytes can be efficiently transduced with HIV-1-derived lentiviral vectors. Upon transduction using LV-PGK-GFP lentiviral vector at 100 ng p24 per 10(5) cells, more than 95% of the 3T3-L1 adipocytes in the culture expressed the GFP reporter gene. There were no overt signs of toxicity or cytopathogenicity in the cultures. Furthermore, modification of undifferentiated preadipocytes did not affect their capacity to differentiate. In addition, insulin-induced glucose uptake was not affected by the procedure. In contrast, adenoviral-mediated gene transfer into 3T3-L1 adipocytes is associated with marked cytopathogenicity. From these data, we conclude that lentiviral vectors are the gene-transfer system of choice for genetic modification of mature adipocytes. The availability of an efficient vector system may stimulate the use of adipose tissue as a target for gene therapy in obesity and other disorders.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 48 条
  • [21] Efficient transfer of regulated genes in adipocytes and hepatoma cells by the combination of liposomes and replication-deficient adenovirus
    MeunierDurimort, C
    Ferry, N
    Hainque, B
    Delattre, J
    Forest, C
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 237 (03): : 660 - 667
  • [22] Global analysis of cellular transcription following infection with an HIV-based vector
    Mitchell, R
    Chiang, CY
    Berry, C
    Bushman, F
    [J]. MOLECULAR THERAPY, 2003, 8 (04) : 674 - 687
  • [23] Development of a self-inactivating lentivirus vector
    Miyoshi, H
    Blömer, U
    Takahashi, M
    Gage, FH
    Verma, IM
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (10) : 8150 - 8157
  • [24] Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
    Miyoshi, H
    Smith, KA
    Mosier, DE
    Verma, IM
    Torbett, BE
    [J]. SCIENCE, 1999, 283 (5402) : 682 - 686
  • [25] Multilineage cells from adipose tissue as gene delivery vehicles
    Morizono, K
    De Ugarte, DA
    Zhu, M
    Zuk, P
    Elbarbary, A
    Ashjian, P
    Benhaim, P
    Chen, ISY
    Hedrick, MH
    [J]. HUMAN GENE THERAPY, 2003, 14 (01) : 59 - 66
  • [26] In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
    Naldini, L
    Blomer, U
    Gallay, P
    Ory, D
    Mulligan, R
    Gage, FH
    Verma, IM
    Trono, D
    [J]. SCIENCE, 1996, 272 (5259) : 263 - 267
  • [27] Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes
    Nguyen, TH
    Oberholzer, J
    Birraux, J
    Majno, P
    Morel, P
    Trono, D
    [J]. MOLECULAR THERAPY, 2002, 6 (02) : 199 - 209
  • [28] Orlicky DJ, 2001, J LIPID RES, V42, P460
  • [29] Orlicky DJ, 2001, J LIPID RES, V42, P910
  • [30] Specific tumor-cell killing with adenovirus vectors containing the apoptin gene
    Pietersen, AM
    van der Eb, MM
    Rademaker, HJ
    van den Wollenberg, DJM
    Rabelink, MJWE
    Kuppen, PJK
    van Dierendonck, JH
    van Ormondt, H
    Masman, D
    van de Velde, CJH
    van der Eb, AJ
    Hoeben, RC
    Noteborn, MHM
    [J]. GENE THERAPY, 1999, 6 (05) : 882 - 892